Insilico Medicine
An AI-native drug discovery company that uses artificial intelligence to accelerate the identification of drug candidates, including a drug for lung fibrosis developed with reported 70% reduction in discovery time.
Recently discussed in
What creators say
"I just spent this past week with Alex Zhavoronkov, the CEO of Insilico Medicine. He just put into phase three a drug that's reversing six aging clocks by four to six years."
More from Peter Diamandis →Keep exploring
Topics
About this data
- ✓45,000+ mentions extracted from real podcast transcripts
- ✓Every quote links to the source episode
- ✓Sponsored mentions are always labeled
- ✓Critical takes are shown, never filtered out